Neurocrine Biosciences Executive Offloads $1.79M in Shares Amid Pipeline Developments
Darin Lippoldt, the Chief Legal Officer at Neurocrine Biosciences Inc. (NASDAQ: NBIX), executed a sale of 10,000 shares of the company's common stock on July 9, 2026, totaling approximately $1.79 million. The transaction was conducted under a Rule 10b5-1 trading plan established prior to the sale. This activity occurs as the company navigates a per…